Cullinan Therapeutics raises target price to $35 from $30
CGEM•H.C. Wainwright raised its target price for Cullinan Therapeutics to $35 from $30.
Related News
GRAIL Inc: Mizuho raises target price to $100 from $65
GRAL•
Atlas Energy Solutions signs cost reimbursement deals with frontier AI lab for data center power equipment
AESI•
U.S. FDA approves Welireg plus Lenvima for certain previously treated adults with advanced renal cell carcinoma
MRK•
Duke Energy names Insight Enterprises ex-CEO Joyce Mullen to board, Audit Committee
DUK•
US-sanctioned oil tanker Sibu 1 rescued from Somali pirates
USO•